Filing Impact
Filing Sentiment
Form Type
4
Absci Corp
Jul 29, 2025
[SCHEDULE 13G] Absci Corporation SEC Filing
Jul 25, 2025
[8-K] Absci Corporation Reports Material Event
Jul 16, 2025
[SCHEDULE 13G/A] Absci Corporation SEC Filing
419.71M
130.15M
9.6%
59.77%
24.35%
Biotechnology
Services-commercial Physical & Biological Research
United States
VANCOUVER